Bioextrax AB (publ)

Stockholm Stock Exchange BIOEX.ST

Bioextrax AB (publ) Capital Expenditure for the year ending December 31, 2023: USD -108.57 K

Bioextrax AB (publ) Capital Expenditure is USD -108.57 K for the year ending December 31, 2023, a 83.22% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Bioextrax AB (publ) Capital Expenditure for the year ending December 31, 2022 was USD -647.11 K, a -502.74% change year over year.
  • Bioextrax AB (publ) Capital Expenditure for the year ending December 31, 2021 was USD -107.36 K, a -486.64% change year over year.
  • Bioextrax AB (publ) Capital Expenditure for the year ending December 31, 2020 was USD -18.30 K, a 71.84% change year over year.
  • Bioextrax AB (publ) Capital Expenditure for the year ending December 31, 2019 was USD -64.99 K, a -398.77% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
SV Wall Street
Stockholm Stock Exchange: BIOEX.ST

Bioextrax AB (publ)

CEO Mr. Edvard Hall
IPO Date April 28, 2020
Location Sweden
Headquarters Skiffervägen 76
Employees 13
Sector Health Care
Industries
Biotechnology Oil Extraction Paper & Forest Products
Description

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.

StockViz Staff

February 5, 2025

Any question? Send us an email